Methods for Identifying Candidate Therapeutics for Antibody-Mediated Inflammatory Demyelinating Disease Using Single-Cell RNA Sequencing of Cerebrospinal Fluid and Transcriptomic Reversal Scoring — Provisional Patent Specification

Ähnliche Einträge

• Single-Cell Transcriptomic Identification of Drug Repurposing Candidates for Ankylosing Spondylitis via PBMC scRNA-seq and ChEMBL Target Screening
  von: Ritschel, Glen Charles, et al.
  Veröffentlicht: (2026)
• Identification of PIK3CG and SYK as Dual Therapeutic Targets in Parkinson's Disease Microglia via Single-Cell RNA Sequencing and Computational Drug Repurposing
  von: Ritschel, Glen Charles, et al.
  Veröffentlicht: (2026)
• Computational Drug Repurposing for Inflammaging Using Single-Cell RNA Sequencing of Peripheral Blood Mononuclear Cells from Aged and Young Donors — Provisional Patent Specification
  von: Ritschel, Glen Charles, et al.
  Veröffentlicht: (2026)
• Supplementary Data: Identification of hematopoietic cell state markers in acute leukemia using explainable machine learning
  von: Chen, David
  Veröffentlicht: (2025)
• Asc-Seurat: Analytical single-cell Seurat-based web application
  von: Almeida, Felipe M., et al.
  Veröffentlicht: (2026)